Friday, May 1, 2026

NVIDIA Surpasses Earnings Expectations, But Stock Drops 2% After Hours

NVIDIA's earnings beat expectations, but stock drops 2% post-announcement, indicating market disappointment despite strong revenue growth.

Opposition Party: “Discord Between Ministry of Unification and Presidential Office Foreign Affairs Line Driven by Competition for Hegemony… Only Kim Jong Un Benefits”

The People Power Party criticizes internal discord affecting South Korea's national security and U.S. alliance ahead of North Korea policy talks.

OUTLAW CORPORATE: NY-Listed Coupang Dodges $10M Fine—But Faces $700M US Punitive Damages

A class-action lawsuit is filed against Coupang Inc. for a data breach affecting millions, seeking punitive damages in the U.S. judicial system.

Tag: Lazertinib

Yuhan’s Leclaza and J&J’s Rybrevant: How This Cancer Combo Surged Past 1 Billion USD in Sales

Sales of Yuhan's lung cancer drug 'Lazertinib' and J&J's 'Amivantamab' exceeded 1 trillion won last year.

Top News

- Our Sponsors Ad -

Follow us